MGC receives permission for first import of Psilocybin
Filed with ASX · · 2 pages · English
Story so far
Earlier from Argent Biopharma
- Commitments Received for GBP 0.7m
- AMC Places Second Order of ArtemiC for US$1M
- Malta Production Facility Receives EU-GMP Approval
- Fundraise closed raising up to a total of GBP 2.09m
- CannEpil now available by Named Patient Request in UK
Later from Argent Biopharma
- MGC Pharma Launches Share Purchase Plan
- Pre-clinical Trial Results on CimetrA
- Share Purchase Plan Closed
- Pause in trading
- Retraction of Statement
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma